The video series, “Advances in the Diagnosis and Management of Multiple Sclerosis,” also will include future perspectives on upcoming MS therapies, and discuss the measures used to assess patients’ clinical outcomes.
“At the moment, there is no available cure for multiple sclerosis, but treatment plans exist that can modify the course of the disease,” Michael J. Hennessy Jr., president of MJH Associates, parent company of NeurologyLive, said in a press release.
“This cutting-edge video series will explore current treatment options and methods for patients, the value of early treatment and how early identification is related to preserving long-term function,” Hennessy said.
The initiative is part of of NeurologyLive‘s most recent “Peer Exchange” panel discussion among six MS medical experts:
- Moderator Fred Lublin, MD, the Saunders Family professor of neurology at the Icahn School of Medicine at Mount Sinai in New York City, and director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis;
- Patricia K. Coyle, MD, professor and vice chair of clinical affairs and director of the Multiple Sclerosis Comprehensive Care Center at Stony Brook University, New York;
- Suhayl S. Dhib-Jalbut, MD, professor and chairman of neurology and the Ruth Dunietz Kushner and Michael Jay Serwitz chair in MS at Rutgers Robert Wood Johnson Medical School and New Jersey Medical School;
- Thomas P. Leist, MD, PhD, director of the Comprehensive Multiple Sclerosis Center at Thomas Jefferson University in Philadelphia, Pennsylvania;
- Clyde E. Markowitz, MD, director of the Multiple Sclerosis Center at the University of Pennsylvania and associate professor of neurology at the Perelman School of Medicine;
- James M. Stankiewicz, MD, clinical director of Partners Multiple Sclerosis Center and assistant professor of neurology at Harvard Medical School, Cambridge, Massachusetts.
The first part of the video series will be dedicated to the diagnosis of MS, and include a debate about the last revisions implemented in the 2017 McDonald criteria, a set of guidelines designed to aid physicians diagnosing MS in clinical practice.
In addition, the panel of experts will discuss physical signs, as well as the most recent diagnostic tools and technologies currently available that can hasten MS diagnosis and reduce the chances of misdiagnosis.
The videos are available here.